RAFAEL HOLDINGS, INC. Other Cash Equivalents, at Carrying Value
RAFAEL HOLDINGS, INC. (RFL) had Other Cash Equivalents, at Carrying Value of $26.50 million as of 2022-07-31, per its 10-K filed 2022-10-31.
Discontinued › Notes
us-gaap:OtherCashEquivalentsAtCarryingValue · last filed 2022-10-31
- 2022-07-31: Other Cash Equivalents, at Carrying Value $26.50M.
- 2022-04-30: Other Cash Equivalents, at Carrying Value $29.00M.
- 2022-01-31: Other Cash Equivalents, at Carrying Value $65.00M.
- 2021-10-31: Other Cash Equivalents, at Carrying Value $72.40M.
| Period end | Other Cash Equivalents, at Carrying Value |
|---|---|
| 2022-07-31 | $26.50M 10-K · filed 2022-10-31 |
| 2022-04-30 | $29.00M 10-Q · filed 2022-06-14 |
| 2022-01-31 | $65.00M 10-Q · filed 2022-03-17 |
| 2021-10-31 | $72.40M 10-Q/A · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |